Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals | News Direct

Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals

News release by Braxia Scientific Corp.

facebook icon linkedin icon twitter icon pinterest icon email icon Vancouver | February 07, 2023 12:02 PM Eastern Standard Time

Braxia Scientific CEO Dr Roger McIntyre joined Steve Darling from Proactive to share news the company has agreed to a non-binding amended and restated letter of intent for a business combination with Irwin Naturals Inc.

McIntyre told Proactive the transaction assembles an experienced management and scientific team in mental health treatment, research and development. The combined company will have 17 specialized mental health clinics across North America, an enhanced telehealth platform and access to critical treatments for millions of people across multiple states in the US.

 

 

 

Contact Details

 

Proactive Canada

 

+1 604-688-8158

 

na-editorial@proactiveinvestors.com

Tags

proactiveinvestorsbraxiascientificcorpirwinnaturalscsebraxotcbraxfketaminepsilocybininvestinvestinginvestmentinvestorstockmarketstocksstockstockmarketnews